Cargando…
The oncolytic adenovirus VCN-01 promotes anti-tumor effect in primitive neuroectodermal tumor models
Last advances in the treatment of pediatric tumors has led to an increase of survival rates of children affected by primitive neuroectodermal tumors, however, still a significant amount of the patients do not overcome the disease. In addition, the survivors might suffer from severe side effects caus...
Autores principales: | Garcia-Moure, Marc, Martinez-Velez, Naiara, Gonzalez-Huarriz, Marisol, Marrodán, Lucía, Cascallo, Manel, Alemany, Ramón, Patiño-García, Ana, Alonso, Marta M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779892/ https://www.ncbi.nlm.nih.gov/pubmed/31591461 http://dx.doi.org/10.1038/s41598-019-51014-1 |
Ejemplares similares
-
Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01
por: Vera, Beatriz, et al.
Publicado: (2016) -
Correction: Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01
por: Vera, Beatriz, et al.
Publicado: (2016) -
Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors
por: Garcia-Carbonero, Rocio, et al.
Publicado: (2022) -
VCN-01 disrupts pancreatic cancer stroma and exerts antitumor effects
por: Bazan-Peregrino, Miriam, et al.
Publicado: (2021) -
Oncolytic adenoviruses as a therapeutic approach for osteosarcoma: A new hope
por: Garcia-Moure, Marc, et al.
Publicado: (2016)